Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA1885 TrachelogeninSummary: Trachelogenin ((-)-Trachelogenin) is an entry inhibitor with no genotype specificity and low cytotoxicity. -
BA1886 Nucleoside-Analog-1Summary: Nucleoside-Analog-1, an analog of antiviral nucleoside R1479, was used in the synthesis of HCV antiviral nucleoside analogs. -
BA1887 KIN1400Summary: KIN1400 is a potent activator. -
BA1888 HCV-IN-29Summary: A hepatitis C virus inhibitor. -
BA1889 BMS-929075Summary: BMS-929075 is a potent orally active NS5B replicase palindromic site-modified inhibitor. -
BA1890 γ-FagarineSummary: Gamma-Fagarine is a naturally occurring furanquinoline alkaloid. -
BA1891 VoxilaprevirSummary: Voxilaprevir (GS-9857) is a non-covalent, reversible protease inhibitor (PI) with pan-antiviral activity. -
BA1892 JTK-109Summary: JTK-109 is a potent inhibitor of hepatitis C virus RNA-dependent RNA polymerase. -
BA1893 TucaresolSummary: Tucaresol is an orally bioavailable immune-enhancing drug that enhances T helper cell activity. -
BA1895 ABBV-744Summary: ABBV-744 is a first-of-its-kind, orally active and selective BDII structural domain of the BET family of proteins.

